Ligand validation:8BDI

QF7: (2~{S},4~{R})-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[(1~{S})-3-(methylamino)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-3-oxidanylidene-propyl]-4-oxidanyl-pyrrolidine-2-carboxamide

QF7 is a Ligand Of Interest in 8BDI designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8BDI_QF7_I_301	22%	70%	0.245	0.862	0.57	0.6	2	-	2	0	100%	1
8BDI_QF7_C_301	21%	68%	0.254	0.865	0.56	0.66	1	1	0	0	100%	1
8BDI_QF7_L_301	21%	70%	0.259	0.868	0.57	0.57	2	-	1	0	100%	1
8BDI_QF7_F_301	9%	70%	0.309	0.798	0.57	0.6	2	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.